Experimental pill achieves complete cancer remission in 18 people with aggressive leukemia
The new drug, called revumenib, has completely eliminated cancer in a third of the participants in a long-awaited clinical study from the University of Texas.
This archive collects solutions-journalism stories and milestones from the United States — covering policy wins, community-led efforts, scientific advances, and social progress happening across the country. Each entry highlights what’s working and why it matters.
The new drug, called revumenib, has completely eliminated cancer in a third of the participants in a long-awaited clinical study from the University of Texas.
The new law establishes a broader slate of protections for LGBTQ+ people by defining gender and sex in state law and expanding existing definitions of sexual orientation and gender identity.
The Danish drugmaker will reduce the list price of its NovoLog insulin by 75%, and for Novolin and Levemir by 65%.
Walz’s executive order parallels legislation awaiting a floor vote in the state House to make Minnesota a “trans refuge state.”
In 2006, the U.S. EPA banned the agricultural use of lindane, linked to anemia, lung cancer, and lymphoma. In 2010, it began to phase out endosulfan, which experts say may damage the liver and kidneys.
The expungement is the latest byproduct of the constitutional amendment approved by Missouri voters, which legalized pot for adults and cleared the way for Missourians to have their records cleared.
For ages, caste has governed nearly every aspect of Hindu religious and social life, with each group maintaining a distinct position in this complicated hierarchy.
The law adds sexual orientation and gender identity to the state’s law prohibiting discrimination based on individual characteristics in housing, employment, and public accommodation in public services and educational facilities.
Insulin costs in the U.S. are notoriously high compared to the costs in other countries; the Rand Corporation, a public policy think tank, estimated that in 2018, the average list price for one vial of insulin in the U.S. was $98.70.
REI aims to have all cookware and apparel sold in its stores free of PFAS by fall of 2024. PFAS have been linked to cancer and other health problems.